Zhaobin Cai

664 total citations
16 papers, 463 citations indexed

About

Zhaobin Cai is a scholar working on Infectious Diseases, Molecular Biology and Cancer Research. According to data from OpenAlex, Zhaobin Cai has authored 16 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Zhaobin Cai's work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Zhaobin Cai is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Zhaobin Cai collaborates with scholars based in China, Australia and Singapore. Zhaobin Cai's co-authors include Aifang Xu, Miaochan Wang, Huaizhong Cui, Zhongbao Zuo, Ying Wang, Fei Ye, Jianjun Xi, Rangxiao Zhuang, Shourong Liu and Jingjing Sun and has published in prestigious journals such as Bioorganic & Medicinal Chemistry, Biomedicine & Pharmacotherapy and International Journal of Infectious Diseases.

In The Last Decade

Zhaobin Cai

14 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhaobin Cai China	10	209	95	70	38	37	16	463
Yanwei Chen China	14	96 0.5×	286 3.0×	61 0.9×	27 0.7×	31 0.8×	59	635
R Cvetković New Zealand	6	278 1.3×	91 1.0×	68 1.0×	38 1.0×	15 0.4×	10	543
Dina Moustafa Abo El-Ella Egypt	7	183 0.9×	135 1.4×	31 0.4×	21 0.6×	21 0.6×	9	449
Olga A. Khomich Russia	5	130 0.6×	142 1.5×	160 2.3×	21 0.6×	14 0.4×	9	495
Ying Xuan Chen China	9	257 1.2×	294 3.1×	50 0.7×	16 0.4×	44 1.2×	17	663
Shaobo Wang China	9	162 0.8×	244 2.6×	57 0.8×	13 0.3×	44 1.2×	14	541
Tsunemichi Hosokawa Japan	10	141 0.7×	91 1.0×	136 1.9×	19 0.5×	9 0.2×	23	478
Lucy Meunier France	13	51 0.2×	116 1.2×	122 1.7×	101 2.7×	45 1.2×	44	546
W. Seifert Netherlands	17	248 1.2×	124 1.3×	305 4.4×	65 1.7×	26 0.7×	33	811
Nilay Thakkar United States	9	59 0.3×	117 1.2×	79 1.1×	47 1.2×	12 0.3×	17	467

Countries citing papers authored by Zhaobin Cai

Since Specialization

Citations

This map shows the geographic impact of Zhaobin Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaobin Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaobin Cai more than expected).

Fields of papers citing papers by Zhaobin Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaobin Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaobin Cai. The network helps show where Zhaobin Cai may publish in the future.

Co-authorship network of co-authors of Zhaobin Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaobin Cai. A scholar is included among the top collaborators of Zhaobin Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaobin Cai. Zhaobin Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Feng, Lei, Qiushi Feng, Yan Mo, et al.. (2025). Trends in cognitive impairment among older adults in China from 2002 to 2022: Evaluating the impact of the COVID-19 pandemic. The Journal of Prevention of Alzheimer s Disease. 13(1). 100370–100370.

Wu, Jian, Zhaobin Cai, Haijun Huang, et al.. (2022). Effects of Different Therapeutic Schedules on Patients with COVID-19: A Prospective Case–Control Study in China. 2022. 1–10. 4 indexed citations

Zhang, Songping, et al.. (2020). Emergency management practice of novel coronavirus pneumonia in designated hospitals/ 中华医院管理杂志. Zhonghua yiyuan guanli zazhi. 36(12).

Wang, Miaochan, Zhongbao Zuo, Fei Ye, et al.. (2020). Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019. International Journal of Infectious Diseases. 94. 49–52. 215 indexed citations

Xie, Zhijun, Zhaobin Cai, Shourong Liu, et al.. (2020). Clinical Characteristics of 60 COVID-19-Infected Patients with or Without Renal Injury In Hangzhou, China. SSRN Electronic Journal. 1 indexed citations

Cai, Zhaobin, Shourong Liu, Jianjun Xi, et al.. (2020). Protective effect of apigenin magnesium complex on H₂O₂-induced oxidative stress and inflammatory responses in rat hepatic stellate cells. Pharmaceutical Biology. 58(1). 553–560. 26 indexed citations

Liu, Fang, Zhaobin Cai, Wenyan Yu, et al.. (2020). Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up. Pathogens and Disease. 78(4). 18 indexed citations

Xu, Keyang, Xu Zhao, Xiaoqing Fu, et al.. (2019). Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study. Biomedicine & Pharmacotherapy. 117. 109158–109158. 25 indexed citations

Xi, Jianjun, Ruoyu He, Jiankang Zhang, et al.. (2019). Design, synthesis, and biological evaluation of novel 3‐(thiophen‐2‐ylthio)pyridine derivatives as potential multitarget anticancer agents. Archiv der Pharmazie. 352(8). e1900024–e1900024. 5 indexed citations

10.

Cai, Zhaobin, et al.. (2017). TIEG1 deficiency confers enhanced myocardial protection in the infarcted heart by mediating the Pten/Akt signalling pathway. International Journal of Molecular Medicine. 39(3). 569–578. 17 indexed citations

11.

Cai, Zhaobin, et al.. (2017). Protective effect of N-acetylcysteine activated carbon release microcapsule on myocardial ischemia-reperfusion injury in rats. Experimental and Therapeutic Medicine. 15(2). 1809–1818. 7 indexed citations

12.

Zhao, Yanmei, Jiankang Zhang, Rangxiao Zhuang, et al.. (2017). Synthesis and evaluation of a series of pyridine and pyrimidine derivatives as type II c-Met inhibitors. Bioorganic & Medicinal Chemistry. 25(12). 3195–3205. 16 indexed citations

13.

Cai, Zhaobin, et al.. (2017). Long noncoding RNA in liver cancer stem cells.. PubMed. 24(131). 87–93. 13 indexed citations

14.

Shi, Tingting, et al.. (2015). [Effect of apigenin on protein expressions of PPARs in liver tissues of rats with nonalcoholic steatohepatitis].. PubMed. 23(2). 124–9. 10 indexed citations

15.

Cai, Zhaobin, et al.. (2015). N-acetylcysteine protects against liver injure induced by carbon tetrachloride via activation of the Nrf2/HO-1 pathway.. PubMed. 8(7). 8655–62. 66 indexed citations

16.

Liu, Shourong, et al.. (2014). Protective effects of N-acetylcysteine on cisplatin-induced oxidative stress and DNA damage in HepG2 cells. Experimental and Therapeutic Medicine. 8(6). 1939–1945. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact